糖尿病智能监护仪很快进入临床一期和二期临床测试和申请国家药监局三类医疗器械注册认证，预计2023年1月可以上市销售。
Diabetes Smart Monitor DSM-169 has been developed successfully and will be applied CFDA for medical use soon.
Copyright © 2023 Baidade Group LLC - All Rights Reserved. Customer Privacy Policy